Vimarsana
Biggest News Aggregation in the World

Page 26 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione' - Vimarsana News

SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione'

Seoul [South Korea], November 24 (ANI/Global Economic): SK Bioscience on Wednesday said that it is not producing finished products of Korea's first COVID-19 vaccine Sky Covione due to its low vaccination rate.

Cell Counting Market Report 2022: Featuring Abbott, Becton - Vimarsana News

Cell Counting Market Report 2022: Featuring Abbott, Becton

Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Cell Counting Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By...

Sintalica Bioscience Corp.: Sintalica Bioscience Announces Key Approval Milestones from the Italian Health Authority - Vimarsana News

Sintalica Bioscience Corp.: Sintalica Bioscience Announces Key Approval Milestones from the Italian Health Authority

Sintalica Bioscience Corp. ("Sintalica" or the "Company"), a psychedelic drug discovery company focused on breakthrough treatments for neuroinflammatory disorders, today announced that the Company has

Satellos Bioscience Inc.: Satellos Bioscience Announces Q3 2022 Financial Results and Operational Highlights - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience Announces Q3 2022 Financial Results and Operational Highlights

Toronto, Ontario--(Newsfile Corp. - November 23, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a drug discovery company developing therapeutics to regenerate muscle

Skye Bioscience, Inc.: Skye Bioscience to Present at RHK 2022 Disruptive Growth Conference - Vimarsana News

Skye Bioscience, Inc.: Skye Bioscience to Present at RHK 2022 Disruptive Growth Conference

San Diego, California--(Newsfile Corp. - November 22, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative